Argentus Capital Management’s Novartis NVS Stock Holding History

Argentus Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,936	Closed	-$149K	–	655
2015 Q4	$149K	Sell	1,936 -3,622	-65%	-$288K	0.05%	317
2015 Q3	$458K	Buy	+5,558	New	+$495K	0.07%	251
2014 Q4	–	Sell	-11,207	Closed	-$945K	–	344
2014 Q3	$945K	Sell	11,207 -324	-3%	-$26.2K	0.15%	175
2014 Q2	$935K	Sell	11,531 -5,151	-31%	-$405K	0.25%	100
2014 Q1	$1.27M	Sell	16,682 -2,089	-11%	-$152K	0.31%	63
2013 Q4	$1.35M	Sell	18,771 -704	-4%	-$48.9K	0.29%	70
2013 Q3	$1.34M	Buy	+19,475	New	+$1.29M	0.31%	57

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

Argentus Capital Management's NVS Position: Q1 2016 in Review

Argentus Capital Management sold out of Novartis (NVS) in Q1 2016, closing a stake of 1,936 shares — an estimated $149K sold.

Argentus Capital Management first reported a position in NVS in Q3 2013 and held it in 7 quarters. The position peaked at $1.35M in Q4 2013. 876 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

Argentus Capital Management reported no remaining Novartis position as of Q1 2016 after selling out during the quarter.
Argentus Capital Management sold 1,936 Novartis shares in Q1 2016, an estimated $149K.
Argentus Capital Management first reported a position in Novartis in Q3 2013 and held it in 7 quarters.
Argentus Capital Management's Novartis position peaked at $1.35M in Q4 2013.
876 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on Argentus Capital Management's 13F filing for Q1 2016, filed 13 May 2016.